ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2556

Deficient Expression of the Novel Rheumatoid Arthritis (RA) Risk Gene, LBH, Induces S Phase Arrest in RA Fibroblast-like Synoviocytes (FLS)

Shinji Matsuda1, Deepa Hammaker2, Steven Dowdy3, David L. Boyle4 and Gary Firestein5, 1Medicine, UC San Diego, La Jolla, CA, 2Division of Rheumatology, Allergy and Immunology, UCSD School of Medicine, La Jolla, CA, 3UC San Diego School of Medicine, La Jolla, CA, 4Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, 5Medicine, UCSD, La Jolla, CA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Epigenetics, Fibroblasts, genomics and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  LBH (Limb-bud and heart development) was recently identified as an RA risk gene that has abnormally methylated loci and a functional enhancer SNP in RA FLS. Low LBH expression has been observed in RA, which affects the cell cycle and contributes to aggressive behavior of RA FLS. We investigated the molecular mechanism of cell cycle regulation by LBH to understand why RA FLS exhibit this characteristic phenotype.

Methods: RA FLS were cultured from synovial tissues obtained at arthroplasty. LBH was knocked down using LBH siRNA, which decreased LBH expression by 88%. Gene expression was measured by qPCR and normalized to ß-actin. Cell cycle analysis was performed with propidium iodide staining and flow cytometry by synchronizing cells by serum starvation and then culturing FLS with 10% FBS. Western blot analysis was used to quantify protein expression and results were normalized to GAPDH.

Results: Cell cycle analysis of RA FLS showed that LBH siRNA silencing decreased S phase progression. The percentage of serum-starved cells in S phase was 2±1%, which increased to 18±4% in control FLS and from 2±1% to 15±4% in LBH-deficient FLS after adding complete medium for 24 hr. However, the percentage of control FLS in S phase decreased to 9±1% in control cells after 38 hr while LBH-silenced cells continued to increased to 25±4% (p<0.05 for control vs. LBH-deficient). These data suggest that LBH deficiency delays S phase progression. To understand the mechanism, we explored the influence of LBH on steps that activate the intra-S phase checkpoint. One key element is DNA replication stress, which can cause the DNA replication forks to stall. LBH-deficient FLS displayed 4±1-fold higher phospho-CHK1 at 24 hr compared to control FLS, which is induced by replication stress (p<0.05). DNA polymerase alpha catalytic subunit (POLA1) is required for initiation of DNA replication in S phase at the replication fork. LBH silencing reduced POLA1 mRNA by 38% (p<0.01) and POLA1 protein by 86% (p<0.01) compared with scrambled siRNA.

Conclusion:  These data show that LBH deficiency reduces POLA1 expression and induces replication stress, which leads to S phase arrest. Lack of progression through S phase arrest in RA FLS could alter the growth patterns of FLS in RA and contribute to their aberrant behavior. Targeting the cell cycle in RA could potentially overcome these pathogenic steps, allow an appropriate response to replication stress, and allow normal progression through the cell cycle.


Disclosure: S. Matsuda, None; D. Hammaker, None; S. Dowdy, None; D. L. Boyle, None; G. Firestein, None.

To cite this abstract in AMA style:

Matsuda S, Hammaker D, Dowdy S, Boyle DL, Firestein G. Deficient Expression of the Novel Rheumatoid Arthritis (RA) Risk Gene, LBH, Induces S Phase Arrest in RA Fibroblast-like Synoviocytes (FLS) [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/deficient-expression-of-the-novel-rheumatoid-arthritis-ra-risk-gene-lbh-induces-s-phase-arrest-in-ra-fibroblast-like-synoviocytes-fls/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deficient-expression-of-the-novel-rheumatoid-arthritis-ra-risk-gene-lbh-induces-s-phase-arrest-in-ra-fibroblast-like-synoviocytes-fls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology